CZ:Uncategorized pages (pain-free version): Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Peter Schmitt
(→‎S: done: 4 ciphers)
imported>Meg Taylor
(rm 86 entries completed)
Line 11: Line 11:
{{col-break}}
{{col-break}}
===A===
===A===
{{r|Acid-base imbalance}} <small>{{pl|Acid-base imbalance|status}}</small>
{{r|Adrenergic agent}} <small>{{pl|Adrenergic agent|status}}</small>
{{r|Agyria}} <small>{{pl|Agyria|status}}</small>


{{r|Alfred Cuthbert}} <small>{{pl|Alfred Cuthbert|status}}</small>
{{r|Alfred Cuthbert}} <small>{{pl|Alfred Cuthbert|status}}</small>
{{r|Alkalosis}} <small>{{pl|Alkalosis|status}}</small>
{{r|Amanita virosa}} <small>{{pl|Amanita virosa|status}}</small>


{{r|Amchitka Island}} <small>{{pl|Amchitka Island|status}}</small>
{{r|Amchitka Island}} <small>{{pl|Amchitka Island|status}}</small>
Line 29: Line 19:


{{r|Anti-spam techniques}} <small>{{pl|Anti-spam techniques|status}}</small>
{{r|Anti-spam techniques}} <small>{{pl|Anti-spam techniques|status}}</small>
{{r|Antihypertensive}} <small>{{pl|Antihypertensive|status}}</small>
{{r|Antilipemic agent}} <small>{{pl|Antilipemic agent|status}}</small>


{{r|Arnold Naudain}} <small>{{pl|Arnold Naudain|status}}</small>
{{r|Arnold Naudain}} <small>{{pl|Arnold Naudain|status}}</small>
{{r|Arterial occlusive disease}} <small>{{pl|Arterial occlusive disease|status}}</small>


{{r|Asher Robbins}} <small>{{pl|Asher Robbins|status}}</small>
{{r|Asher Robbins}} <small>{{pl|Asher Robbins|status}}</small>
===B===
===B===
{{r|B-Cell chronic lymphocytic leukemia}} <small>{{pl|B-Cell chronic lymphocytic leukemia|status}}</small>
{{r|BATV}} <small>{{pl|BATV|status}}</small>
{{r|Bacteriocins}} <small>{{pl|Bacteriocins|status}}</small>


{{r|Bahasa Indonesia}} <small>{{pl|Bahasa Indonesia|status}}</small>
{{r|Bahasa Indonesia}} <small>{{pl|Bahasa Indonesia|status}}</small>
Line 51: Line 30:


{{r|Bernard Bujold}} <small>{{pl|Bernard Bujold|status}}</small>
{{r|Bernard Bujold}} <small>{{pl|Bernard Bujold|status}}</small>
{{r|Bisphosphonate}} <small>{{pl|Bisphosphonate|status}}</small>


{{r|Bounce Address Tag Validation}} <small>{{pl|Bounce Address Tag Validation|status}}</small>
{{r|Bounce Address Tag Validation}} <small>{{pl|Bounce Address Tag Validation|status}}</small>


===C===
===C===
{{r|Canine distemper}} <small>{{pl|Canine distemper|status}}</small>


{{r|Capitation fee}} <small>{{pl|Capitation fee|status}}</small>
{{r|Capitation fee}} <small>{{pl|Capitation fee|status}}</small>
{{r|Carboplatin}} <small>{{pl|Carboplatin|status}}</small>


{{r|Catalyzing an energy revolution}} <small>{{pl|Catalyzing an energy revolution|status}}</small>
{{r|Catalyzing an energy revolution}} <small>{{pl|Catalyzing an energy revolution|status}}</small>
{{r|Catecholamine plasma membrane transport protein}} <small>{{pl|Catecholamine plasma membrane transport protein|status}}</small>
{{r|Chondroitin}} <small>{{pl|Chondroitin|status}}</small>
{{r|Complement C4}} <small>{{pl|Complement C4|status}}</small>
{{r|Coordinates}} <small>{{pl|Coordinates|status}}</small>
{{r|Crowding}} <small>{{pl|Crowding|status}}</small>
{{r|Cytochrome P-450 CYP2D6}} <small>{{pl|Cytochrome P-450 CYP2D6|status}}</small>


===D===
===D===
{{r|Dabigatran}} <small>{{pl|Dabigatran|status}}</small>


{{r|Degrassi Junior High}} <small>{{pl|Degrassi Junior High|status}}</small>
{{r|Degrassi Junior High}} <small>{{pl|Degrassi Junior High|status}}</small>
{{r|Denervation}} <small>{{pl|Denervation|status}}</small>
{{r|Depression}} <small>{{pl|Depression|status}}</small>
{{r|Dopamine plasma membrane transport protein}} <small>{{pl|Dopamine plasma membrane transport protein|status}}</small>
{{r|Dopamine receptor}} <small>{{pl|Dopamine receptor|status}}</small>
{{r|Dopamine uptake inhibitor}} <small>{{pl|Dopamine uptake inhibitor|status}}</small>


{{r|Draft:Test Article}} <small>{{pl|Draft:Test Article|status}}</small>
{{r|Draft:Test Article}} <small>{{pl|Draft:Test Article|status}}</small>


{{r|Dreamcast}} <small>{{pl|Dreamcast|status}}</small>
{{r|Dreamcast}} <small>{{pl|Dreamcast|status}}</small>
{{r|Drug interaction}} <small>{{pl|Drug interaction|status}}</small>


===E===
===E===
Line 113: Line 60:


{{r|Email port 587}} <small>{{pl|Email port 587|status}}</small>
{{r|Email port 587}} <small>{{pl|Email port 587|status}}</small>
{{r|Entrez Gene}} <small>{{pl|Entrez Gene|status}}</small>
{{r|ErbB-2 receptor}} <small>{{pl|ErbB-2 receptor|status}}</small>


{{r|Ether Shepley}} <small>{{pl|Ether Shepley|status}}</small>
{{r|Ether Shepley}} <small>{{pl|Ether Shepley|status}}</small>
{{r|Etoposide}} <small>{{pl|Etoposide|status}}</small>


{{r|Extended SMTP}} <small>{{pl|Extended SMTP|status}}</small>
{{r|Extended SMTP}} <small>{{pl|Extended SMTP|status}}</small>
Line 129: Line 70:


{{r|Felix Grundy}} <small>{{pl|Felix Grundy|status}}</small>
{{r|Felix Grundy}} <small>{{pl|Felix Grundy|status}}</small>
{{r|Femur}} <small>{{pl|Femur|status}}</small>
{{r|Fishing sinker}} <small>{{pl|Fishing sinker|status}}</small>
{{r|Fludrocortisone}} <small>{{pl|Fludrocortisone|status}}</small>
{{r|Forgiveness}} <small>{{pl|Forgiveness|status}}</small>
{{r|Franz Kafka}} <small>{{pl|Franz Kafka|status}}</small>


===G===
===G===


{{r|Gabriel Moore}} <small>{{pl|Gabriel Moore|status}}</small>
{{r|Gabriel Moore}} <small>{{pl|Gabriel Moore|status}}</small>
{{r|Galactosidase}} <small>{{pl|Galactosidase|status}}</small>


{{r|George A. Waggaman}} <small>{{pl|George A. Waggaman|status}}</small>
{{r|George A. Waggaman}} <small>{{pl|George A. Waggaman|status}}</small>
Line 153: Line 82:


{{r|Gideon Tomlinson}} <small>{{pl|Gideon Tomlinson|status}}</small>
{{r|Gideon Tomlinson}} <small>{{pl|Gideon Tomlinson|status}}</small>
{{r|Glucose tolerance test}} <small>{{pl|Glucose tolerance test|status}}</small>
{{r|Glutamate decarboxylase}} <small>{{pl|Glutamate decarboxylase|status}}</small>
{{r|Graft vs host disease}} <small>{{pl|Graft vs host disease|status}}</small>


===H===
===H===
Line 166: Line 89:


{{r|Healthcare quality assurance}} <small>{{pl|Healthcare quality assurance|status}}</small>
{{r|Healthcare quality assurance}} <small>{{pl|Healthcare quality assurance|status}}</small>
{{r|Hemianopsia}} <small>{{pl|Hemianopsia|status}}</small>
{{r|Hepatitis E}} <small>{{pl|Hepatitis E|status}}</small>
{{r|Hip fracture}} <small>{{pl|Hip fracture|status}}</small>


{{r|History of communication}} <small>{{pl|History of communication|status}}</small>
{{r|History of communication}} <small>{{pl|History of communication|status}}</small>
Line 179: Line 96:
===I===
===I===
{{r|IP blacklist}} <small>{{pl|IP blacklist|status}}</small>
{{r|IP blacklist}} <small>{{pl|IP blacklist|status}}</small>
{{r|Immunoenzyme technique}} <small>{{pl|Immunoenzyme technique|status}}</small>
{{r|Insulin-secreting cell}} <small>{{pl|Insulin-secreting cell|status}}</small>


{{r|Integral cryptanalysis}} <small>{{pl|Integral cryptanalysis|status}}</small>
{{r|Integral cryptanalysis}} <small>{{pl|Integral cryptanalysis|status}}</small>
Line 191: Line 104:


{{r|Internet Message Access Protocol}} <small>{{pl|Internet Message Access Protocol|status}}</small>
{{r|Internet Message Access Protocol}} <small>{{pl|Internet Message Access Protocol|status}}</small>
{{r|Intratracheal intubation}} <small>{{pl|Intratracheal intubation|status}}</small>
{{r|Ischemic colitis}} <small>{{pl|Ischemic colitis|status}}</small>
{{col-break}}
{{col-break}}


Line 220: Line 129:


{{r|Khalid al-Mihdhar}} <small>{{pl|Khalid al-Mihdhar|status}}</small>
{{r|Khalid al-Mihdhar}} <small>{{pl|Khalid al-Mihdhar|status}}</small>
{{r|Knee joint}} <small>{{pl|Knee joint|status}}</small>


{{r|Kohlberg Kravis Roberts & Co.}} ]<small>{{pl|Kohlberg Kravis Roberts & Co.|status}}</small>]
{{r|Kohlberg Kravis Roberts & Co.}} ]<small>{{pl|Kohlberg Kravis Roberts & Co.|status}}</small>]
Line 227: Line 134:
===L===
===L===
{{r|LOKI (cipher)}} <small>{{pl|LOKI (cipher)|status}}</small>
{{r|LOKI (cipher)}} <small>{{pl|LOKI (cipher)|status}}</small>
{{r|Lactic acid}} <small>{{pl|Lactic acid|status}}</small>


{{r|Launch of the Citizendium}} <small>{{pl|Launch of the Citizendium|status}}</small>
{{r|Launch of the Citizendium}} <small>{{pl|Launch of the Citizendium|status}}</small>
Line 237: Line 142:


{{r|List of viperine species and subspecies}} <small>{{pl|List of viperine species and subspecies|status}}</small>
{{r|List of viperine species and subspecies}} <small>{{pl|List of viperine species and subspecies|status}}</small>
{{r|Lough Neagh}} <small>{{pl|Lough Neagh|status}}</small>
{{r|Lymphocyte count}} <small>{{pl|Lymphocyte count|status}}</small>


===M===
===M===
Line 248: Line 149:


{{r|Max Baucus}} <small>{{pl|Max Baucus|status}}</small>
{{r|Max Baucus}} <small>{{pl|Max Baucus|status}}</small>
{{r|Medical Research Council dyspnea scale}} <small>{{pl|Medical Research Council dyspnea scale|status}}</small>


{{r|Meggido}} <small>{{pl|Meggido|status}}</small>
{{r|Meggido}} <small>{{pl|Meggido|status}}</small>
{{r|Mesenteric ischemia}} <small>{{pl|Mesenteric ischemia|status}}</small>
{{r|Metoclopramide}} <small>{{pl|Metoclopramide|status}}</small>


{{r|Mission San Luis Rey de Francia}} <small>{{pl|Mission San Luis Rey de Francia|status}}</small>
{{r|Mission San Luis Rey de Francia}} <small>{{pl|Mission San Luis Rey de Francia|status}}</small>
{{r|Monoamine oxidase}} <small>{{pl|Monoamine oxidase|status}}</small>


===N===
===N===
Line 269: Line 162:


{{r|Natural stress relief meditation}} <small>{{pl|Natural stress relief meditation|status}}</small>
{{r|Natural stress relief meditation}} <small>{{pl|Natural stress relief meditation|status}}</small>
{{r|Neck injury}} <small>{{pl|Neck injury|status}}</small>


{{r|Nehemiah R. Knight}} <small>{{pl|Nehemiah R. Knight|status}}</small>
{{r|Nehemiah R. Knight}} <small>{{pl|Nehemiah R. Knight|status}}</small>
Line 277: Line 168:


===O===
===O===
{{r|One & Other}} <small>{{pl|One & Other|status}}</small>
{{r|One & Other}} <small>{{pl|One & Other|status}}</small>
{{r|Order (mathematics)}} <small>{{pl|Order (mathematics)|status}}</small>
{{r|Otitis media}} <small>{{pl|Otitis media|status}}</small>


===P===
===P===
{{r|Patient satisfaction}} <small>{{pl|Patient satisfaction|status}}</small>


{{r|Peleg Sprague}} <small>{{pl|Peleg Sprague|status}}</small>
{{r|Peleg Sprague}} <small>{{pl|Peleg Sprague|status}}</small>
{{r|Pessimism}} <small>{{pl|Pessimism|status}}</small>
{{r|Photon absorptiometry}} <small>{{pl|Photon absorptiometry|status}}</small>
{{r|Place setting}} <small>{{pl|Place setting|status}}</small>
{{r|Plantaris muscle}} <small>{{pl|Plantaris muscle|status}}</small>
{{r|Portal vein thrombosis}} <small>{{pl|Portal vein thrombosis|status}}</small>
{{r|Premedication}} <small>{{pl|Premedication|status}}</small>
{{r|Probe}} <small>{{pl|Probe|status}}</small>
{{r|Propranolol}} <small>{{pl|Propranolol|status}}</small>
{{r|Prostate specific antigen}} <small>{{pl|Prostate specific antigen|status}}</small>
{{r|Proteinuria}} <small>{{pl|Proteinuria|status}}</small>


{{r|Provincial Reconstruction Team}} <small>{{pl|Provincial Reconstruction Team|status}}</small>
{{r|Provincial Reconstruction Team}} <small>{{pl|Provincial Reconstruction Team|status}}</small>
{{r|Psychomotor agitation}} <small>{{pl|Psychomotor agitation|status}}</small>
{{r|Pulmonary hypertension}} <small>{{pl|Pulmonary hypertension|status}}</small>
{{r|Pyelonephritis}} <small>{{pl|Pyelonephritis|status}}</small>


===R===
===R===
{{r|RF electronics}} <small>{{pl|RF electronics|status}}</small>


{{r|Relay (computers)}} <small>{{pl|Relay (computers)|status}}</small>
{{r|Relay (computers)}} <small>{{pl|Relay (computers)|status}}</small>
Line 338: Line 198:


{{r|Sender Rewriting Scheme}} <small>{{pl|Sender Rewriting Scheme|status}}</small>
{{r|Sender Rewriting Scheme}} <small>{{pl|Sender Rewriting Scheme|status}}</small>
{{r|Serologic test}} <small>{{pl|Serologic test|status}}</small>


{{r|Serpent (cipher)}} <small>{{pl|Serpent (cipher)|status}}</small>
{{r|Serpent (cipher)}} <small>{{pl|Serpent (cipher)|status}}</small>
{{r|Sigmoidoscopy}} <small>{{pl|Sigmoidoscopy|status}}</small>


{{r|Spawn (computing)}} <small>{{pl|Spawn (computing)|status}}</small>
{{r|Spawn (computing)}} <small>{{pl|Spawn (computing)|status}}</small>
{{r|Splenic vein thrombosis}} <small>{{pl|Splenic vein thrombosis|status}}</small>
{{r|Steatohepatitis}} <small>{{pl|Steatohepatitis|status}}</small>


{{r|Syndication (Citizendium)}} <small>{{pl|Syndication (Citizendium)|status}}</small>
{{r|Syndication (Citizendium)}} <small>{{pl|Syndication (Citizendium)|status}}</small>
{{r|Systemic inflammatory response syndrome}} <small>{{pl|Systemic inflammatory response syndrome|status}}</small>


===T===
===T===
{{r|Tactical and Technical Intelligence Subcommittee}} <small>{{pl|Tactical and Technical Intelligence Subcommittee|status}}</small>
{{r|Tactical and Technical Intelligence Subcommittee}} <small>{{pl|Tactical and Technical Intelligence Subcommittee|status}}</small>
{{r|Tamsulosin}} <small>{{pl|Tamsulosin|status}}</small>


{{r|Third Way}} <small>{{pl|Third Way|status}}</small>
{{r|Third Way}} <small>{{pl|Third Way|status}}</small>
Line 365: Line 213:


{{r|Tiny Encryption Algorithm}} <small>{{pl|Tiny Encryption Algorithm|status}}</small>
{{r|Tiny Encryption Algorithm}} <small>{{pl|Tiny Encryption Algorithm|status}}</small>
{{r|Tiotropium}} <small>{{pl|Tiotropium|status}}</small>


{{r|Title goes here}} <small>{{pl|Title goes here|status}}</small>
{{r|Title goes here}} <small>{{pl|Title goes here|status}}</small>
{{r|Transjugular intrahepatic portosystemic shunt}} <small>{{pl|Transjugular intrahepatic portosystemic shunt|status}}</small>


{{r|Treasury Inflation-Protected Securities}} <small>{{pl|Treasury Inflation-Protected Securities|status}}</small>
{{r|Treasury Inflation-Protected Securities}} <small>{{pl|Treasury Inflation-Protected Securities|status}}</small>
Line 379: Line 223:


===U===
===U===
{{r|U.K. Special Forces}} <small>{{pl|U.K. Special Forces|status}}</small>


{{r|U.S. intelligence activities in Nigeria}} <small>{{pl|U.S. intelligence activities in Nigeria|status}}</small>
{{r|U.S. intelligence activities in Nigeria}} <small>{{pl|U.S. intelligence activities in Nigeria|status}}</small>
Line 392: Line 235:


===V===
===V===
{{r|VKORC1}} <small>{{pl|VKORC1|status}}</small>
{{r|Vitamin E}} <small>{{pl|Vitamin E|status}}</small>


===W===
===W===
{{r|W. S. Gilbert}} <small>{{pl|W. S. Gilbert|status}}</small>


{{r|Washington Naval Treaty}} <small>{{pl|Washington Naval Treaty|status}}</small>
{{r|Washington Naval Treaty}} <small>{{pl|Washington Naval Treaty|status}}</small>


{{r|Webmail}} <small>{{pl|Webmail|status}}</small>
{{r|Webmail}} <small>{{pl|Webmail|status}}</small>
{{r|Weight}} <small>{{pl|Weight|status}}</small>


{{r|William C. Preston}} <small>{{pl|William C. Preston|status}}</small>
{{r|William C. Preston}} <small>{{pl|William C. Preston|status}}</small>

Revision as of 18:58, 30 September 2009

This is a list of uncategorized Citizendium pages - those which show up under uncategorized pages but without the definition subpages etc. which make that list difficult to work through. Uncategorized pages are not included in the total number of live articles we have (currently 16,420).

This list is current as of 30th September 2009, but is not being automatically updated. At present, it lists over 200 pages which may be articles, but could be material that does not meet CZ standards, mistakes, test pages, and so on. They need to be categorized using the {{subpages}} template, moved somewhere else (such as cold storage or catalogs) or deleted. Definitions may also be added.

Please remove pages from the list once you've dealt with them. Next to each name you can see the status colour of each page. If status is purple, that page is uncategorized. Blue means that a metadata page exists, but the {{subpages}} template may not have been added to the top of the article.

Note that inherently short pages can be made into lemma articles, which require a Definition page and a main page, the latter containing only the line {{subpages}}. Lemma article may have Related Articles, Bibliography, and External Links.

Begin the list!

A

  • Amnesty International [r]: International non-governmental organisation, founded in London in 1961, which draws attention to human rights abuses and campaigns for compliance with international standards. [e] Developing Article status

B

  • Baptist Church [r]: A group of Protestant churches, associations, and denominations that emphasize believer's baptism and congregational polity. [e] Developing Article status

C

D

  • Dreamcast [r]: A sixth generation videogame console released by Sega in 1998 in Japan and 1999 in North America and Europe. [e] Developing Article status

E

  • Email abuse [r]: The unsolicited sending of spam, third party advertisements, derogatory language, slander, and threats via electronic mail. [e] Stub status
  • Email greylisting [r]: A spam prevention method in which the receiving mail server rejects a message the first time it is received. [e] Developing Article status

F

G

H

I

J

K

L

M

N

O

P

R

S

T

U

V

W